NCT05931562

Brief Summary

This study aims to investigate the effects of an 8-week dietary intervention on cognitive function, stress, and the gut microbiota in healthy adults with low fibre intake.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable healthy

Timeline
2mo left

Started Jul 2022

Longer than P75 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Jul 2022Jul 2026

Study Start

First participant enrolled

July 14, 2022

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

June 12, 2023

Completed
23 days until next milestone

First Posted

Study publicly available on registry

July 5, 2023

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Last Updated

July 16, 2024

Status Verified

July 1, 2024

Enrollment Period

4 years

First QC Date

June 12, 2023

Last Update Submit

July 15, 2024

Conditions

Keywords

Microbiota-gut-brain axisDietCognitionStressDietary FibreFermented foods

Outcome Measures

Primary Outcomes (5)

  • Trait stress/mood: self-report

    self-report questionnaires

    Change from baseline at 8 weeks

  • Trait stress/mood: hypothalamic-pituitary-adrenal axis activity

    Cortisol from saliva samples

    Change from baseline at 8 weeks

  • Responses to acute stress: self-report

    Self-report questionnaires

    Change from baseline at 8 weeks

  • Responses to acute stress: sympathetic-adrenal-medullary pathway activity

    Galvanic skin response taken from the skin on the hand

    Change from baseline at 8 weeks

  • Responses to acute stress: hypothalamic-pituitary-adrenal axis activity

    Cortisol from saliva samples

    Change from baseline at 8 weeks

Secondary Outcomes (12)

  • Cognitive performance: working memory

    Change from baseline at 8 weeks

  • Cognitive performance: episodic memory

    Change from baseline at 8 weeks

  • Cognitive performance: decision making

    Change from baseline at 8 weeks

  • Cognitive performance: emotional inhibition

    Change from baseline at 8 weeks

  • Cognitive performance: sustained attention

    Change from baseline at 8 weeks

  • +7 more secondary outcomes

Study Arms (4)

Control

ACTIVE COMPARATOR

Participants will recieve dietary education based on the healthy eating guidleines provided by the Health Service Executive (HSE).

Other: Control

Fermented Foods

EXPERIMENTAL

Fermented foods diet (4-6 portions/day)

Other: Fermented Foods

High Fibre

EXPERIMENTAL

High fibre diet (24-35 grams/day)

Other: High Fibre

Combined Diet

EXPERIMENTAL

Combined diet high in fibre and fermented foods (fibre aim 24-35 grams/day, fermented foods aim 4-6 portions/day)

Other: Combined Diet

Interventions

Participants will recieve dietary education to include 4 to 6 portions of fermented foods to their normal diet.

Fermented Foods

Participants will recieve dietary education to increase their fibre intake to 24-35g/day in their normal diet.

High Fibre

Participants will recieve dietary education to increase their fibre intake to 25-30g/day and include 3 to 4 portions of fermented foods to their normal diet.

Combined Diet
ControlOTHER

Participants will recieve dietary education based on the Irish healthy food pyramid.

Control

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Be able to give written informed consent.
  • Be between 18 and 50 years of age.
  • Have a body mass index (BMI) between 18.5-29.9 Kg/m2.
  • Be in generally good health as determined by the investigator.

You may not qualify if:

  • Are less than 18 and greater than 50 years of age.
  • Have a BMI below 18.5 or above 29.9 Kg/m2.
  • Have a significant acute or chronic coexisting illness \[cardiovascular, gastrointestinal (GI) \[to include functional GI disorders, inflammatory bowel disease, coeliac disease, lactose intolerance, food allergies\], immunological, psychiatric \[to include formal or as determined by MINI Psychiatric interview, diagnosis of current major depression, anxiety disorder, bipolar spectrum disorder, schizophrenia, other DSM-IV Axis I disorder\], neurodevelopmental disorders, immunological, metabolic disorders \[to include type I or II diabetes\], or any condition which contraindicates, in the investigators judgement, entry to the study,
  • Have a condition or taking a medication that the investigator believes would interfere with the objectives of the study, pose a safety risk, or confound the interpretation of the study results; all psychoactive medications \[to include anxiolytics, antipsychotics, antidepressants, anticonvulsants, centrally acting corticosteroids, and opioid pain relievers), laxatives, enemas, antibiotics, anti-coagulants, over-the counter non-steroidal anti-inflammatories (NSAIDS). Subjects should have a wash-out period of 4 weeks.
  • Current prebiotic or probiotic supplement use (a wash-out period of 4 weeks after cessation will allow entry to the study).
  • Females who are peri-menopausal, menopausal or post-menopausal.
  • Females who are pregnant or planning a pregnancy, or lactating.
  • Participants who are not fluent in English.
  • Are colour blind.
  • Have dyslexia or dyscalculia.
  • Are a current habitual daily smoker.
  • Individuals who, in the opinion of the investigator, are considered to be poor attendees or unlikely for any reason to be able to comply with the trial.
  • Subjects receiving treatment involving experimental drugs. If the subject has been in a recent experimental trial, these must have been completed not less than 30 days prior to this study.
  • Have a malignant disease or any concomitant end-stage organ disease.
  • Have completed a study in our laboratory in the past 4 years.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

APC Microbiome Ireland

Cork, T12YT20, Ireland

RECRUITING

MeSH Terms

Interventions

Fermented Foods

Intervention Hierarchy (Ancestors)

Diet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • John Cryan, PhD

    APC Microbiome Ireland

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Elizabeth Schneider, PhD

CONTACT

Revathy Munuswamy

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
FACTORIAL
Model Details: Randomized-controlled, parallel, single-blinded design
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 12, 2023

First Posted

July 5, 2023

Study Start

July 14, 2022

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

July 16, 2024

Record last verified: 2024-07

Locations